Essential role of genetics in the advancement of biotechnology

Methods in Molecular Biology

Volumn 898, Issue , 2012, Pages 1-40

  Demain, Arnold L ^a   Adrio, José L ^b,c  

^a DREW UNIVERSITY   (United States)

^b Neuron BioIndustrial Division   (Spain)

^c Parque Tecnologico de Ciencias de la Salud   (Spain)

Author keywords

Agriculture; Bioconversions; Biopharmaceuticals; Enzymes; Genetic engineering; Hosts; Metabolic engineering; Polymers; Primary metabolites; Secondary metabolites

Indexed keywords

DRUG; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIOTECHNOLOGY; CELL LINE; GENETIC PROCEDURES; GENETICS; HUMAN; METABOLISM; METABOLOME; METHODOLOGY;

ANIMALS; BIOTECHNOLOGY; CELL LINE; GENETIC TECHNIQUES; HUMANS; METABOLOME; PHARMACEUTICAL PREPARATIONS; RECOMBINANT PROTEINS;

EID: 84864148372     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-918-1_1     Document Type: Article

References (261)

1. Ohnishi J, Mitsuhashi S, Hayashi M, Ando S, Yokoi H, Ochiai K et al (2002) A novel methodology employing Corynebacterium glutamicum genome information to generate a new L-lysine-producing mutant. Appl Microbiol Biotechnol 58:217-223
2. Stephanopoulos G (1999) Metabolic fl uxes and metabolic engineering. Metab Eng 1:1-11
3. Nielsen J (2001) Metabolic engineering. Appl Microbiol Biotechnol 55:263-283
4. Sahm H, Eggeling L, De Graaf AA (2000) Pathway analysis and metabolic engineering in Corynebacterium glutamicum . Biol Chem 381:899-910
5. Santos CSS, Stephanopoulos G (2008) Combinatorial engineering of microbes for optimizing cellular phenotype. Curr Opin Chem Biol 12:168-176
6. Bailey JE, Sburlati A, Hatzimanikatis V, Lee K, Renner WA, Tsai PS (1996) Inverse metabolic engineering: A strategy for directed genetic engineering of useful phenotypes. Biotechnol Bioeng 52:109-121
7. Ness JE, del Cardayre SB, Minshull J, Stemmer WP (2000) Molecular breeding: The natural approach to protein design. Adv Protein Chem 55:261-292
8. Zhao H, Arnold FH (1997) Optimization of DNA shuf fl ing for high fi delity recombination. Nucleic Acids Res 25:1307-1308
9. Patten PA, Howard RJ, Stemmer WP (1997) Applications of DNA shuf fl ing to pharmaceuticals and vaccines. Curr Opin Biotechnol 8:724-733
10. Zhang YX, Perry K, Vinci VA, Powell K, Stemmer WP, del Cardayre SB (2002) Genome shuf fl ing leads to rapid phenotypic improvement in bacteria. Nature 415: 644-646
11. Hou L (2009) Novel methods of genome shuf fl ing in Saccharomyces cerevisiae . Biotechnol Lett 31:671-677
12. Stephanopoulos G, Alper H, Moxley J (2004) Exploiting biological complexity for strain improvement through systems biology. Nat Biotechnol 22:1261-1267
13. Leuchtenberger W, Huthmacher K, Drauz K (2005) Biotechnological production of amino acids and derivatives: Current status and prospects. Appl Microbiol Biotechnol 69:1-8
14. Liu Q, Zhang J, Wei X-X, Ouyang S-P, Wu Q, Chen G-Q (2008) Microbial production of L-glutamate and L-glutamine by recombinant Corynebacterium glutamicum harboring Vitreoscilla hemoglobin gene vgb . Appl Microbiol Biotechnol 77:1297-1304
15. Chinen A, Kozlov YI, Hara Y, Izui H, Yasueda H (2007) Innovative metabolic pathway design for Efficient L-glutamate production by suppreassing CO 2 emission. J Biosci Bioeng 103:262-269
16. Ohnishi J, Katahira R, Mitsuhashi S, Kakita S, Ikeda M (2005) A novel gnd mutation leading to increased L-lysine production in Corynebacterium glutamicum . FEMS Microbiol Lett 242:265-274
17. Ikeda M, Ohnishi J, Hayashi M, Mitsuhashi S (2006) A genome-based approach to create a minimally mutated Corynebacterium glutamicum strain for Efficient L-lysine production. J Ind Microbiol Biotechnol 33:610-615
18. Hiyashi M, Ohnishi J, Mitsuhashi S, Yonetani Y, Hashimoto S, Ikeda M (2006) Transcriptome analysis reveals global expression changes in an industrial L-lysine producer of Corynebacterium glutamicum . Biosci Biotechnol Biochem 70:546-550
19. Radmacher E, Eggeling L (2007) The three tricarboxylate synthase activities of Corynebacterium glutamicum and increase of L-lysine synthesis. Appl Microbiol Biotechnol 76:587-595
20. Blombach B, Schreiner ME, Moch M, Oldiges M, Eikmanns BJ (2007) Effect of pyruvate dehydrogenase complex Deficiency on L-lysine production with Corynebacterium glutamicum . Appl Microbiol Biotechnol 76: 615-623
21. Sindelar G, Wendisch VF (2007) Improving lysine production by Corynebacterium glutamicum through DNA microarray-based Identification of novel target genes. Appl Microbiol Biotechnol 76:677-689
22. Komatsubara S, Kisumi M, Chibata I (1979) Transductional construction of a threonineproducing strain of Serratia marcescens . Appl Environ Microbiol 38:1045-1051
23. Komatsubara S, Kisumi M, Chibata I (1983) Transductional construction of a threoninehyperproducing strain of Serratia marcescens: Lack of feedback controls of three aspartokinases and two homoserine dehydrogenases. Appl Environ Microbiol 45:1445-1452
24. Sugita T, Komatsubara S (1989) Construction of a threonine-hyperproducing strain of Serratia marcescens by amplifying the phosphoenolpyruvate carboxylase gene. Appl Microbiol Biotechnol 30:290-293
25. Debabov VG (2003) The threonine story. Adv Biochem Eng Biotechnol 79:113-136
26. Ishida M, Kawashima H, Sato K, Hashiguchi K, Ito H, Enei H et al (1994) Factors improving L-threonine production by a three L-threonine biosynthetic genes-ampli fi ed recombinant strain of Brevibacterium lactofermentum . Biosci Biotechnol Biochem 58:768-770
27. Eggeling L, Sahm H (1999) Amino acid production: Principles of metabolic engineering. In: Lee SY, Papoutsakis ET (eds) Metabolic engineering. Marcel Dekker, New York, pp 153-176
28. Kruse D, Kraemer R, Eggeling L, Rieping M, Pfefferle W, Tchieu JH et al (2002) influence of threonine exporters on threonine production in Escherichia coli . Appl Microbiol Biotechnol 59:205-210
29. Lee KH, Park JH, Kim TY, Kim HU, Lee SY (2007) Systems metabolic engineering of Escherichia coli for L-threonine production. Mol Syst Biol 3:149-157
30. Park JH, Lee KH, Kim TY, Lee SY (2007) Metabolic engineering of Escherichia coli for the production of L-valine based on transcriptome analysis and in silico gene knockout stimulation. Proc Natl Acad Sci USA 104:7797-7802
31. Lange C, Rittmann D, Wendisch VF, Bott M, Sahm H (2003) Global expression profiling and physiological characterization of Corynebacterium glutamicum grown in the presence of L-valine. Appl Environ Microbiol 69:2521-2532
32. Kisumi M, Komatsubara S, Chibata I (1977) Enhancement of isoleucine hydroxamatemediated growth inhibition and improvement of isoleucine-producing strains of Serratia marcescens . Appl Environ Microbiol 34: 647-653
33. Guillouet S, Rodal AA, An G-H, Lessard PA, Sinskey AJ (1999) Expression of the Escherichia coli catabolic threonine dehydratase in Corynebacterium glutamicum and its effect on isoleucine production. Appl Environ Microbiol 65:3100-3107
34. Morbach S, Sahm H, Eggeling L (1996) L-Isoleucine production with Corynebacterium glutamicum: Further fl ux increase and limitation of export. Appl Environ Microbiol 62: 4345-4351
35. Hashiguchi K, Takesada H, Suzuki E, Matsui H (1999) Construction of an L-isoleucine overproducing strain of Escherichia coli K-12. Biosci Biotechnol Biochem 63:672-679
36. Eggeling L, Morbach S, Sahm H (1977) The fruits of molecular physiology: Engineering the L-isoleucine biosynthesis pathway in Corynebacterium glutamicum . J Biotechnol 56:167-182
37. Colon GE, Nguyen TT, Jetten MSM, Sinskey A, Stephanopoulos G (1995) Production of isoleucine by overexpression of ilvA in Corynebacterium lactofermentum threonine producer. Appl Microbiol Biotechnol 43: 482-488
38. Kase H, Nakayama K (1977) L-Isoleucine production by analog-resistant mutants derived from threonine-producing strain of Corynebacterium glutamicum . Agric Biol Chem 41:109-116
39. Morbach S, Sahm H, Eggeling L (1995) Use of feedback-resistant threonine dehydratases of Corynebacterium glutamicum to increase carbon fl ux towards L-isoleucine. Appl Environ Microbiol 61:4315-4320
40. Morbach S, Kelle R, Winkels S, Sahm H, Eggeling L (1996) Engineering the homoserine dehydrogenase and threonine dehydratase control points to analyse fl ux towards L-isoleucine in Corynebacterium glutamicum . Appl Microbiol Biotechnol 45:612-620
41. Sahm H, Eggeling L, Morbach S, Eikmanns B (1999) Construction of L-isoleucineoverproducing strains of Corynebacterium glutamicum . Naturwissenschaften 86:33-38
42. Shiio I, Sasaki A, Nakamori S, Sano K (1973) Production of L-isoleucine by AHV resistant mutants of Brevibacterium fl avum . Agric Biol Chem 37:2053-2061
43. Ikeda S, Fujita I, Hirose Y (1976) Culture conditions of L-isoleucine fermentation from acetic acid. Agric Biol Chem 40:517-522
44. Lee M, Smith GM, Eiteman MA, Altman E (2004) Aerobic production of alanine by Escherichia coli aceF IdhA mutants expressing the Bacillus sphaericus alaD gene. Appl Microbiol Biotechnol 65:56-60
45. Bloom F, Smith CJ, Jessee J, Veileux B, Deutch AH (1984) The use of genetically engineered strains of Escherichia coli for the overproduction of free amino acids: Proline as a model system. In: Downey K, Voellmy RW (eds) Advances in gene technology: Molecular genetics of plants and animals. Academic, New York, pp 383-394
46. Sugiura M, Takagi T, Kisumu M (1995) Proline production by regulatory mutants of Serratia marcescens . Appl Microbiol Biotechnol 21:213-239
47. Sugiura M, Imai Y, Takagi T, Kisumi M (1985) Improvement of a proline-producing strain of Serratia marcescens by subcloning of a mutant allele of the proline gene. J Biotechnol 3:47-58
48. Masuda M, Takamatu S, Nishimura N, Komatsubara S, Tosa T (1993) Improvement of culture conditions for L-proline production by a recombinant strain of Serratia marcescens . Appl Biochem Biotechnol 43:189-197
49. Tsuchida T, Kubota K, Yoshinaga F (1986) Improvement of L-proline production by sulfaguanidine resistant mutants derived from L-glutamic acid-producing bacteria. Agric Biol Chem 50:2201-2207
50. Nakanishi T, Yokote Y, Taketsugu Y (1973) Conversion of L-glutamic acid fermentation to a L-proline fermentation by Corynebacterium glutamicum . J Ferment Technol 51:742-749
51. Nakanishi T, Hirao T, Azuma T, Sakurai M, Hagino H (1987) Application of L-glutamate to L-proline fermentation by Corynebac terium acetoacidophilum . J Ferment Technol 65: 139-144
52. Shibasaki T, Hashimoto S, Mori H, Ozaki A (2000) Construction of a novel hydroxyproline-producing recombinant Escherichia coli by introducing a proline 4-hydroxylase gene. J Biosci Bioeng 90:522-525
53. Vandamme EJ (2007) Microbial gems: Microorganisms without frontiers. SIM News 57:81-90
54. Kamada N, Yasuhara A, Takano Y, Nakano T (2001) Effect of transketolase modifications on carbon flow to the purine-nucleotide pathway in Corynebacterium ammoniagenes . Appl Microbiol Biotechnol 56:710-717
55. Koizumi S, Yonetani Y, Maruyama A, Teshiba S (2000) Production of ribo fl avin by metabolically engineered Corynebacterium ammoniagenes . Appl Microbiol Biotechnol 51: 674-679
56. Perkins JB, Pero J (1993) Biosynthesis of ribo fl avin, biotin, folic acid, and cobalamin. In: Sonenshein AL, Hoch JA, Losick R (eds) Bacillus subtilis and other gram positive bacteria: Biochemistry, physiology and molecular genetics. American Society for Microbiology, Washington, DC, pp 319-334
57. Perkins JB, Sloma A, Hermann T, Theriault K, Zachgo E, Erdenberger T et al (1999) Genetic engineering of Bacillus subtilis for the commercial production of ribo fl avin. J Ind Microbiol Biotechnol 22:8-18
58. Brenner S, Johnson M, Bridgham J, Golda G, Lloyd DH, Johnson D et al (2000) Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol 18:630-634
59. Karos M, Vilarino C, Bollschweiler C, Revuelta JL (2004) A genome wide transcription analysis of a fungal rivo fl avin overproducer. J Biotechnol 113:69-76
60. Levy-Schil S, Debussche L, Rigault S, Soubrier F, Bacchette F, Lagneaux D et al (1993) Biotin biosyntheric pathway in a recombinant strain of Escherichia coli overexpressing bio genes: Evidence for a limiting step upstream from KAPA. Appl Microbiol Biotechnol 38:755-762
61. Sakurai N, Imai Y, Masuda M, Komatsubara S, Tosa T (1994) Improvement of a d-biotinhyperproducing recombinant strain of Serratia marcescens . J Biotechnol 36:63-73
62. Masuda M, Takahashi K, Sakurai N, Yanagiya K, Komatsubara S, Tosa T (1995) Further improvement of D-biotin production by a recombinant strain of Serratia marcescens . Process Biochem 30:553-562
63. Matsui J, Ifuku O, Kanzaki N, Kawamoto T, Nakahama K (2001) Microorganism resistant to threonine analogue and production of biotin. US patent 6284500
64. Anderson S, Marks CB, Lazarus R, Miller J, Stafford K, Seymour J et al (1985) Production of 2-keto- L-gulonate: An intermediate in L-ascorbate synthesis by a genetically modified Erwinia herbicola . Science 230:144-149
65. Grindley JF, Payton MA, Van De Pol H, Hardy KG (1988) Conversion of glucose to 2-keto-L-gulonate, an intermediate in L-ascorbate synthesis, by a recombinant strain of Erwinia citreus . Appl Environ Microbiol 54: 1770-1775
66. Saito Y, Ishii Y, Hayashi H, Imao Y, Akashi T, Yoshikawa K et al (1997) Cloning of genes coding for L-sorbose and L-sorbosone dehydrogenases from Gluconobacter oxydans and microbial production of 2-keto-gulonate, a precursor of L-ascorbic acid, in a recombinant G. oxydans strain. Appl Environ Microbiol 63:454-460
67. DeBaets S, Vandedrinck S, Vandamme EJ (2000) Vitamins and related biofactors, microbial production. In: Lederberg J (ed) Encyclopedia of microbiology, vol 4, 2nd edn. Academic, New York, pp 837-853
68. Johnson EA, Schroeder WA (1995) Microbial carotenoids. Adv Biochem Eng Biotechnol 53:119-178
69. López-Nieto MJ, Costa J, Peiro E, Méndez E, Rodríguez-Sáiz M, De La Fuente JL, Cabri W, Barredo JL (2004) Biotechnological lycopene production by mated fermentation of Blakeslea trispora . Appl Microbiol Biotechnol 66:153-159
70. Ciegler A (1965) Microbial carotenogenesis. Adv Appl Microbiol 7:1-34
71. Ninet L, Renaut J (1979) Carotenoids. In: Peppler HJ, Perlman D (eds) Microbial technology, vol 1, 2nd edn. Academic, New York, pp 529-544
72. Barkovich R, Liao JC (2001) Metabolic engineering of isoprenoids. Metab Eng 3: 27-39
73. Lee PC, Schmidt-Dannert C (2002) Metabolic engineering towards biotechnological production of carotenoids in microorganisms. Appl Microbiol Biotechnol 60:1-11
74. Tao L, Jackson RE, Cheng Q (2005) Directed evolution of copy number of a broad host range plasmid for metabolic engineering. Metab Eng 7:10-17
75. Alper H, Miyaoku K, Stephanopoulos G (2006) Characterization of lycopene-overproducing E. coli strains in high cell density fermentations. Appl Microbiol Biotechnol 72:968-974
76. Fernández-Sevilla JM, Acien Fernández FG, Molina Grima E (2010) Biotechnological production of lutein and its applications. Appl Microbiol Biotechnol 86:27-40
77. Margalith PZ (1999) Production of ketocarotenoids by microalgae. Appl Microbiol Biotechnol 51:431-438
78. Johnson EA (2003) Phaf fi a rhodozyma: A colorful odyssey. Int Microbiol 6:169-174
79. De La Fuente JL, Rodríguez-Sáiz M, Schleissner C, Díez B, Peiro E, Barredo JL (2010) Hightiter production of astaxanthin by the semiindustrial fermentation of Xanthophyllomyces dendrorhous . J Biotechnol 148:144-146
80. Rodríguez-Sáiz M, De La Fuente JL, Barredo JL (2010) Xanthophyllomyces dendrorhous for the industrial production of astaxanthin. Appl Microbiol Biotechnol 88:645-658
81. Sauer M, Porro D, Mattanovich D, Branduardi P (2008) Microbial production of organic acids: Expanding the markets. Trends Biotechnol 26:100-108
82. Sánchez S, Demain AL (2008) Metabolic regulation and overproduction of primary metabolites. Microb Biotechnol 1:283-319
83. Ward OP, Qin WM, Hanjoon JD, Singh EJYA (2006) Physiology and biotechnology of Aspergillus . Adv Appl Microbiol 58:1-75
84. Kubicek CP, Roehr M (1986) Citric acid fermentation. Crit Rev Biotechnol 3:331-373
85. Causey TB, Zhou S, Shanmugam KT, Ingram LO (2003) Engineering the metabolism of Escherichia coli W3110 for the conversion of sugar to redox-neutral and oxidized products: Homoacetate production. Proc Natl Acad Sci USA 100:825-832
86. Parekh SR, Cheryan M (1994) High concentrations of acetate with a mutant strain of C. thermoaceticum . Biotechnol Lett 16: 139-142
87. Fukaya M, Tayama K, Tamaki T, Tagami H, Okumura H, Kawamura Y et al (1989) Cloning of the membrane-bound aldehyde dehydrogenase gene of Acetobacter polyoxogenes and improvement of acetic acid production by use of thecloned gene. Appl Environ Microbiol 55:171-176
88. Patnaik R, Louie S, Gavrilovic V, Perry K, Stemmer WPC, Ryan CM et al (2002) Genome shuf fl ing of Lactobacillus for improved acid tolerance. Nat Biotechnol 20:707-712
89. John RP, Gangadharan D, Madhavan Nampoothiri K (2008) Genome shuf fl ing of Lactobacillus delbrueckii mutant and Bacillus amyloliquuefaciens through protoplastic fusion for L-latic acid production from starchy wastes. Bioresour Technol 99:8008-8015
90. Skory CD (2004) Lactic acid production by Rhizopus oryzae transformants with modified lactate dehydrogenase activity. Appl Microbiol Biotechnol 64:237-242
91. Saito S, Ishida N, Onishi T, Tokuhiro K, Nagamori E, Kitamoto K et al (2005) Genetically engineered wine yeast produces a high concentration of L-lactic acid of extremely high optical purity. Appl Environ Microbiol 71:2789-2792
92. Porro D, Bianchi MM, Brambilla L, Menghini R, Bolzani D, Carrera V et al (1999) Replacement of a metabolic pathway for large scale production of lactic acid from engineered yeasts. Appl Environ Microbiol 65:4211-4215
93. Zhou S, Yomano LP, Shanmugam KT, Ingram LO (2003) Fermentation of 10% (w/v) sugar to D(-)-lactate by engineered Escherichia coli B. Biotechnol Lett 27:1891-1896
94. Ishida N, Suzuki T, Tokuhiro K, Nagamori E, Onishi T, Saitoh S et al (2006) D-Lactic acid production by metabolically engineered Saccharomyces cerevisiae . J Biosci Bioeng 101: 172-177
95. Sánchez AM, Bennett GN, San KY (2005) Novel pathway engineering design of the anaerobic central metabolic pathway in Escherichia coli . Metab Eng 7:229-239
96. Lee SJ, Song H, Lee SY (2006) Genomebased metabolic engineering of Mannheimia succiniciproducens for succinic acid production. Appl Environ Microbiol 72:1939-1948
97. Lin H, Bennett GN, San KY (2005) Fedbatch culture of a metabolically engineered Escherichia coli strain designed for high-level succinate production and yield under aerobic conditions. Biotechnol Bioeng 90:775-779
98. Vemuri GN, Eiteman MA, Altman E (2002) Succinate production in dual-phase Escherichia coli fermentations depends on the time of transition from aerobic to anaerobic conditions. J Ind Microbiol Biotechnol 28: 325-332
99. Liu X, Yang S-T (2005) Metabolic engineering of Clostridium tyrobutyricum for butyric acid fermentation. Proceedings of the 229th ACS National Meeting, San Diego, Abstract 70
100. Neufeld RJ, Peleg Y, Rokem JS, Pines O, Goldberg I (1991) L-Malic acid formation by immobilized Saccharomyces cerevisiae ampli fi ed for fumarase. Enzyme Microb Technol 13:991-996
101. Picataggio S, Rohver T, Deander K, Lanning D, Reynolds R, Mielenz J et al (1992) Metabolic engineering of Candida tropicalis for the production of long-chain dicarboxylic acids. Nat Biotechnol 10:894-898
102. Shi DJ, Wang CL, Wang KM (2009) Genome shuf fl ing to improve thermotolerance, ethanol tolerance and ethanol productivity of Saccharomyces cerevisiae . J Ind Microbiol Biotechnol 36:139-147
103. Chu BCH, Lee H (2007) Genetic improvement of Saccharomyces cerevisiae for xylose fermentation. Biotechnol Adv 25:425-441
104. Jeffries TW (2006) Engineering yeast for xylose metabolism. Curr Opin Biotechnol 17:320-326
105. Bro C, Regenberg B, Forster J, Nielsen J (2006) In silico aided metabolic engineering of Saccharomyces cerevisiae for improved bioethanol production. Metab Eng 8:102-111
106. Wei P, Li Z, He P, Lin Y, Jiang N (2008) Genome shuf fl ing in the ethanologenic yeast Candida krusei to improve acetic acid tolerance. Biotechnol Appl Biochem 49:113-120
107. Ingram LO, Conway T, Clark DP, Sewell GW, Preston JF (1987) Genetic engineering of ethanol production in Escherichia coli . Appl Environ Microbiol 53:2420-2425
108. Doran JB, Ingram LO (1993) Fermentation of crystalline cellulose to ethanol by Klebsiella oxytoca containing chromosomally integrated Zymomonas mobilis genes. Biotechnol Prog 9:533-538
109. Dien BS, Nichols NN, O'Bryan PJ, Bothast RJ (2000) Development of new ethanologenic Escherichia coli strains for fermentation of lignocellulosic biomass. Appl Biochem Biotechnol 84(86):181-196
110. Papanikolaou S, Ruiz-Sánchez P, Pariset B, Blanchard F, Fick M (2000) High production of 1,3-propanediol from industrial glycerol by a newly isolated Clostridium butyricum strain. J Biotechnol 77:191-208
111. Sanford K, Valle F, Ghirnikar R (2004) Pathway engineering through rational design. Tutorial: Designing and building cell factories for biobased production. Genet Eng News 24:44-45
112. Nakamura C, Whited G (2003) Metabolic engineering for the microbial production of 1,3 propanediol. Curr Opin Biotechnol 14:454-459
113. Kaup B, Bringer-Meyer S, Sahm H (2004) Metabolic engineering of Escherichia coli: Construction of an Efficient biocatalyst for D-mannitolformationinawhole-cellbiotransformation. Appl Microbiol Biotechnol 64:333-339
114. Kaup B, Bringer-Meyer S, Sahm H (2005) D-Mannitol formation from D-glucose in a whiole-cell biotransformation with recombinant Escherichia coli . Appl Microbiol Biotechnol 69:397-403
115. Lee J-K, Oh D-K, Song H-Y, Kim I-W (2007) Ca2+ and Cu2+ supplementation increases mannitol production by Candida magnoliae . Biotechnol Lett 29:291-294
116. Song SH, Vieille C (2009) Recent advances in the biological production of mannitol. Appl Microbiol Biotechnol 84:55-62
117. Chun UH, Rogers PL (1988) The simultaneous production of sorbitol and gluconic acid by Zymomonas mobilis . Appl Microbiol Biotechnol 29:19-24
118. Ladero V, Ramos A, Wiersma A, Gof fi n P, Schanck A, Kleerbezem M (2007) High-level; production of the low-calorie sugar sorbitol by Lactobacillus plantarum through metyabolic engineering. Appl Environ Microbiol 73:1864-1872
119. Hermann M, Fayolle F, Marchal R, Podvin L, Sebald M, Vandecasteele J-P (1985) Isolation and characterization of butanol-resistant mutants of Clostridium acetobutylicum . Appl Environ Microbiol 50:1238-1243
120. Qureshi N, Maddox IS, Freidl A (1992) Application of continuous substrate feeding to the ABE fermentation: Relief of product inhibition using extraction, perstraction, stripping and pervaporation. Biotechnol Prog 8:382-390
121. Chen C-K, Blaschek HP (1999) Acetate enhances solvent production and prevents degeneration in Clostridium beijerinckii BA101. Appl Microbiol Biotechnol 52: 170-173
122. Connor MR, Liao JC (2009) Microbial production of advanced transportation fuels in non-natural hosts. Curr Opin Biotechnol 20:307-315
123. Whiters ST, Gottlieb SS, Lieu B, Newman JD, Keasling JD (2007) Identification of isopentenol biosynthetic genes from Bacillus subtilis by a screening method based on isoprenoid precursor toxicity. Appl Environ Microbiol 73:6277-6283
124. Atsumi S, Hanai T, Liao JC (2008) Nonfermentative pathways for synthesis of branched-chain higher alcohols as biofuels. Nature 451:86-89
125. Jeya M, Lee K-M, Tiwari MK, Kim J-S, Gunasekaran P, Kim S-Y, Kim I-W, Lee J-K (2009) Isolation of a novel high erythritolproducing Pseudomonas tsukubaensis and scaleup of erythritol fermentation to industrial level. Appl Microbiol Biotechnol 83:225-231
126. Zagustina NA, Rodionova NA, Mestechkina NM, Shcherbukhin VD, Bezborodov AM (2001) Xylitol production by a culture of Candida guilliermondii 2581. Appl Biochem Microbiol 37:489-492
127. Lederberg J (2000) Pathways of discovery: Infectious history. Science 288:287-293
128. Choi KP, Kim KH, Kim JW (1997) Strain improvement of clavulanic acid producing Streptomyces clavuligerus . Proc 10th Internat Symp Biol Actinomycetes (ISBA), Beijing, Abstr 12, 9
129. Li R, Townsend CA (2006) Rational strain improvement for enhanced clavulanic acid production by genetic engineering of the glycolytic pathway in Streptomyces clavuligerus . Metab Eng 8:240-252
130. Pérez-Redondo RA, Rodríguez-García A, Martín JF, Liras P (1999) Deletion of the pyc gene blocks clavulanic acid biosynthesis except in glycerol-containing medium: Evidence for two different genes in formation of the C3 unit. J Bacteriol 181:6922-6928
131. Paradkar AS, Aiodoo KA, Jensen SE (1998) A pathway-specific transcriptional activator regulates late steps of clavuklanic acid biosynthesis in Streptomyces clavuligerus . Mol Microbiol 27:831-843
132. Pérez-Llarena FJ, Liras P, Rodríguez-García A, Martín JF (1997) A regulatory gene (ccaR ) required for cephamycin and clavulanic acid production in Streptomyces clavuligerus: Amplification results in overproduction of both α?-lactam compounds. J Bacteriol 179: 2053-2059
133. Lein J (1986) The Panlabs penicillin strain improvement program. In: Vanek Z, Hostalek Z (eds) Overproduction of microbial metabolites; strain improvement and process control strategies. Butterworth, Boston, pp 105-139
134. Kennedy J, Turner G (1996) γ?-( L-α-Aminoadipyl)- L-cysteinyl- D-valine synthetase is a rate limiting enzyme for penicillin production in Aspergillus nidulans . Mol Gen Genet 253:189-197
135. Hamlyn PF, Ball C (1979) Recombination studies with Cephalosporium acremonium . In: Sebek OK, Laskin AI (eds) Genetics of industrial microorganisms. American Society for Microbiology, Washington, DC, pp 185-191
136. Skatrud PL, Fisher DL, Ingolia TD, Queener SW (1987) Improved transformation of Cephalosporium acremonium . In: Alacevic M, Hranueli D, Toman Z (eds) Genetics of industrial microorganisms, part B. Zagreb, Pliva, pp 111-119
137. Skatrud PL, Tietz AJ, Ingolia TD, Cantwell CA, Fisher DL, Chapman JL et al (1989) Use of recombinant DNA to improve production of cephalosporin C by Cephalosporium acremonium . Nat Biotechnol 7:477-485
138. Wesseling AC, Lago B (1981) Strain improvement by genetic recombination of cephamycin producers, Nocardia lactamdurans and Streptomyces griseus . Dev Ind Microbiol 22:641-651
139. Chary VK, De La Fuente JL, Leitao AL, Liras P, Martín JF (2000) Overexpression of the lat gene in Nocardia lactamdurans from strong heterologous promoters results in very high levels of lysine-6-aminotransferase and up to a two-fold increase in cephamycin C production. Appl Microbiol Biotechnol 53:282-288
140. Bignell DRD, Tahlan K, Colvin KR, Jensen SE, Leskiw BK (2005) Expression of ccaR encoding the positive activator of cephamycin C and clavulanic acid production in Streptomyces clavuligerus is dependent on bldG . Antimicrob Agents Chemother 49:1529-1541
141. Cantwell C, Beckmann R, Whiteman P, Queener SW, Abraham EP (1992) Isolation of deacetoxycephalosporin C from fermentation broths of Penicillium chrysogenum transformants: Construction of a new fungal 248:283-289
142. Crawford L, Stepan AM, Mcada PC, Rambosek JA, Conder MJ, Vinci VA et al (1995) Production of cephalosporin intermediates by feeding adipic acid to recombinant Penicillium chrysogenum strains expressing ring expansion activity. Nat Biotechnol 13:58-62
143. Velasco J, Adrio JL, Moreno MA, Díez B, Soler G, Barredo JL (2000) Environmentally safe production of 7-aminodeacetoxycephalosporanic acid (7ADCA) using recombinant strains of Acremonium chrysogenum . Nat Biotechnol 18:857-861
144. Luo H, Yu H, Qiang L, Shen Z (2004) Cloning and co-expression of D-amino acid oxidase and glutaryl-7-aminocephalosporanic acid acylase genes in Escherichia coli . Enzyme Microb Technol 35:514-518
145. Coulthurst SJ, Barnard AM, Salmond GP (2005) Regulation and biosynthesis of carbapenem antibiotics in bacteria. Nat Rev Microbiol 3:295-306
146. Kahan JS, Kahan FM, Goegelman R, Currie SA, Jackson M, Stapley EO, Miller TW, Miller AK, Hendlin D, Mochales S, Hernandez S, Woodruff HB, Birnbaum J (1979) Thienamycin, a new α?-lactam antibiotic. 1. Discovery, taxonomy, isolation and physical properties. J Antibiot 32:1-12
147. Park SR, Han AR, Ban Y-H, Yoo YJ, Kim EJ et al (2010) Genetic engineering of macrolide biosynthesis: Past advances, current state and future prospects. Appl Microbiol Biotechnol 85:1227-1239
148. Reeves AR, Cernota WH, Brikun IA, Wesley RK, Weber JM (2004) Engineering precursor flow for increased erythromycin production in Aeromicrobium erythreum . Metab Eng 6:300-312
149. Solenberg PJ, Cantwell CA, Tietz AJ, McGilvray D, Queener SW, Baltz RH (1996) Transposition mutagenesis in Streptomyces fradiae: Identification of a neutral site for the stable insertion of DNA by transposon exchange. Gene 16:67-72
150. Brautaset T, Sletta H, Nedal A, Borgos SEF, Degnes KF, Bakke I, Volokhan O, Sekurova ON, Treshalin ID, Mirchink EP, Dikiy A, Ellingsen TE, Zotchev SB (2008) Improved antifungal polyene macrolides via engineering of the nystatin biosynthetic genes in Streptomyces noursei . Chem Biol 15:1198-1206
151. Galm U, Shen B (2006) Expression of biosynthetic gene clusters in heterologous hosts for natural product production and combinatorial biosynthesis. Expet Opin Drug Discov 1:409-437
152. Méndez C, Salas JA (2003) On the generation of novel anticancer drugs by recombinant DNA technology: The use of combinatorial biosynthesis to produce novel drugs. Comb Chem High Throughput Screen 6:513-526
153. Rodríguez E, McDaniel R (2001) Combinatorial biosynthesis of antimicrobials and other natural products. Curr Opin Microbiol 4: 526-534
154. Trefzer A, Blanco G, Remsing L, Kunzel E, Rix U, Lipata F et al (2002) Rationally designed glycosylated premithramycins: Hybrid aromatic polyketides using genes from three different biosynthetic pathways. J Am Chem Soc 124:6056-6062
155. Gomi S, Ikeda D, Nakamura H, Naganawa H, Yamashita F, Hotta K et al (1984) Isolation and structure of a new antibiotic, indolizomycin, produced by a strain SK2-52 obtained by interspecies fusion treatment. J Antibiot 37:1491-1494
156. Traxler P, Schupp T, Wehrli W (1982) 16, 17-dihydrorifamycin S and 16,17-dihydro-17-hydroxyrifamycin S, two novel rifamycins from a recombinant strain C5/42 of Nocardia mediterranei . J Antibiot 35:594-601
157. Okanishi M, Suzuki N, Furuta T (1996) Variety of hybrid characters among recombinants obtained by interspecific protoplast fusion in streptomycetes. Biosci Biotechnol Biochem 60:1233-1238
158. Zhou L, Ahlert J, Xue Y, Thorson JS, Sherman DH, Liu H-W (1999) Engineering a methymycin/pikromycin-calicheamicin hybrid: Construction of two new macrolides carrying a designed sugar moiety. J Am Chem Soc 121:9881-9882
159. Méndez C, Salas JA (2001) Altering the glycosylation pattern of bioactive compounds. Trends Biotechnol 19:449-456
160. Decker H, Hutchinson CR (1993) Transcriptional analysis of the Streptomyces glaucescens tetracenomycin biosynthesis gene cluster. J Bacteriol 175:3887-3892
161. Wohlert S-E, Blanco G, Lombo F, Fernández E, Brana AF, Reich S, Udvarnoki G, Méndez C, Decker H, Frevert J et al (1998) Novel hybrid tetracenomycins through combinatorial biosynthesis using a glycosyltransferase encoded by the elm genes in cosmid 16 F4 which shows a very broad sugar substrate specificity. J Am Chem Soc 120: 10596-10601
162. Barriere JC, Berthaud N, Beyer D, Dutka-Malen S, Paris JM, Desnottes JF (1998) Recent developments in streptogramin research. Curr Pharm Des 4:155-180
163. Xu B, Jin Z, Wang H, Jin Q, Jin X et al (2008) Evolution of Streptomyces pristinaespiralis for resistance and production of pristinamycin by genome shuf fl ing. Appl Microbiol Biotechnol 80:261-267
164. Van Lanen SG, Shen B (2006) Microbial genomics for the improvement of natural product discovery. Curr Opin Microbiol 9:252-260
165. Jenke-Kodama H, Sandmann A, Müller R, Dittmann E (2005) Evolutionary implications of bacterial polyketide synthases. Mol Biol Evol 22:2027-2039
166. Zazopoulos E, Hwang K, Staffa A, Liu W, Bachmann BO, Nonaka K et al (2003) A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nat Biotechnol 21:187-190
167. Moir DT, Shaw KJ, Hare RS, Vovis GF (1999) Genomics and antimicrobial drug discovery. Antimicrob Agents Chemother 43:439-446
168. Newman DJ, Shapiro S (2008) Microbial prescreens for anticancer activity. SIM News 58:132-150
169. Hwang CK, Kim HS, Hong YS, Kim YH, Hong SK, Kim SJ, Lee JJ (1995) Expression of Streptomyces peucetius genes for doxorubicin resistance and aklavinone 11-hydroxylase in Streptomyces galilaeus ATCC 31133 and production of a hybrid aclacinomycin. Antimicrob Agents Chemother 39: 1616-1620
170. Kim HS, Hong YS, Kim YH, Yoo OJ, Lee JJ (1996) New anthracycline metabolites produced by the aklavinone 11-hydroxylase gene in Streptomyces galilaeus ATCC 3113. J Antibiot 49:355-360
171. Niemi J, Mäntäslä P (1995) Nucleotide sequences and
172. Ylihonko K, Hakala J, Kunnari T, Mäntsälä P (1996) Production of hybrid anthracycline antibiotics by heterologous expression of Streptomyces nogalater nogalamycin biosynthesis genes. Microbiology 142:1965-1972
173. Strohl WR, Bartel PL, Li Y, Connors NC, Woodman RH (1991) Expression of polyketide biosynthesis and regulatory genes in heterologous streptomycetes. J Ind Microbiol 7:163-174
174. Bartel PL, Zhu CB, Lampel JS, Dosch DC, Connors NC, Strohl WR, Beale JM Jr, Floss HG (1990) Biosynthesis of anthraquinones by interspecies cloning of actinorhodin genes in streptomycetes: Clari fi cation of actinorhodin gene functions. J Bacteriol 172: 4816-4826
175. Arcamone F, Penco S, Vigevani A, Redaelli S, Franchi G, Di Marco A, Casazza AM, Dasdia T, Formelli F, Necco A, Soranzo C (1975) Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone. J Med Chem 18:703-707
176. Madduri K, Kennedy J, Rivola G, Inventi-Solari A, Filippini S, Zanuso G, Colombo AL, Gewain KM, Occi JL, MacNeil DJ, Hutchinson CR (1998) Production of the antitumor drug epirubicin (4 ¢-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius . Nat Biotechnol 16:69-74
177. Manfredi JJ, Horowitz SB (1984) Taxol: An antimitotic agent with a new mechanism of action. Pharmacol Ther 25:83-125
178. Horwitz SB (1994) Taxol (paclitaxel): Mechanisms of action. Ann Oncol 5(Suppl 6): S3-S6
179. Dejong JM, Liu Y, Bollon AP, Long RM, Jennewein S, Williams D, Croteau RB (2005) Genetic engineering of taxol biosynthetic genes in Saccharomyces cerevisiae . Biotechnol Bioeng 93:212-224
180. Engels B, Dahm P, Jennewein S (2008) Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (Paclitaxel) production. Metab Eng 10: 201-206
181. Borzlleri RM, Vite GD (2002) Epothilones: New tubulin polymerization agents in preclinical and clinical development. Drugs Future 27:1149-1163
182. Brown AG, Smale TC, King TJ, Hasenkamp R, Thompson RH (1976) Crystal and molecular structure of compactin: A new antifungal metabolite from Penicillium brevicompactum . J Chem Soc Perkin Trans I (11):1165-1170
183. Endo A, Kuroda M, Tsujita Y (1976) ML-236B and ML-236 C, new inhibitors of cholesterolgenesis produced by Penicillium citrinun . J Antibiot 29:1346-1348
184. Endo A (1979) Monacolin K, a new hypocholesterolemic agent produced by Monascus species. J Antibiot 32:852-854
185. Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C et al (1980) Mevinolin: A highly potent competitive inhibitor of hydroxymethylglutaryl- coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA 77:3957-3961
186. Askenazi M, Driggers EM, Holtzman DA, Norman TC, Iverson S, Zimmer DP et al (2003) Integrating transcriptional and metabolite pro fi les to direct the engineering of lovastatin-producing fungal strains. Nat Biotechnol 21:150-156
187. Stapley EO (1982) Avermectins, antiparasitic lactones produced by Streptomyces avermitilis isolated from a soil in Japan. In: Umezawa H, Demain AL, Hata R, Hutchinson CR (eds) Trends in antibiotic research. Japan Antibiotic Research Association, Tokyo, pp 154-170
188. Lee J-Y, Hwang Y-S, Kim S-S, Kim E-S, Choi C-Y (2000) Effect of a global regulatory gene, afsR2 from Streptomyces lividans on avermectin production in Streptomyces avermitilis . Biosci Bioeng 89:606-608
189. Ikeda H, Takada Y, Pang C-H, Tanaka H, Omura S (1993) Transposon mutagenesis by Tn4560 and applications with avermectinproducing Streptomyces avermitilis . J Bacteriol 175:2077-2082
190. Stutzman-Engwall K, Conlon S, Fedechko R, McArthur H, Pekrun K, Chen Y, Jenne S, La C, Trinh N, Kim S, Zhang Y-X, Fox R, Gustafsson C, Krebber A (2005) Semisynthetic DNA shuf fl ing of aveC leads to improved industrial scale production of doramectin by Streptomyces avermitilis . Metab Eng 7:27-37
191. Zhang X, Chen Z, Li M, Wen Y, Song Y, Li J (2006) Construction of ivermectin producer by domain swaps of avermectin polyketide synthase in Streptomyces avermitilis . Appl Microbiol Biotechnol 72:986-994
192. McArthur HIA (1998) The novel avermectin, Doramectin-a successful application of mutasynthesis. In: Hutchinson CR, McAlpine J (eds) Developments in industrial microbiology-BMP 97. Society for Industrial Microbiology, Fairfax, pp 43-48
193. Vezina C, Kudelski A, Sehgal SN (1975) Rapamycin (AY 22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot 28:721-726
194. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H (1987) FK-506, a novel immunosuppressant isolated from Streptomyces . I. Fermentation, isolation and physico-chemical and biological characteristics. J Antibiot 40:1249-1255
195. Jung S, Moon S, Lee K, Park Y-J, Yoon S et al (2009) Strain development of Streptomyces sp. for tacrolimus production using sequential adaptation. J Ind Microbiol Biotechnol 36:1467-1471
196. Chen X, Wei P, Fan L, Yang D, Zhu X, Shen W et al (2009) Generation of high-yield rapamycin-producing strains through protoplast-related techniques. Appl Microbiol Biotechnol 83:507-512
197. Kuscer E, Coates N, Challis I, Gregory M, Wilkinson B, Sheridan R, Petkovic H (2007) Roles of rapH and rapG in positive regulation of rapamycin biosynthesis in Streptomyces hygroscopicus . J Bacteriol 189:4756-4763
198. Jin ZH, Xu B, Lin SZ, Jin QC, Cen PL (2009) Enhanced production of spinosad in Saccharopolyspora spinosa by genome shuf fl ing. Appl Biochem Biotechnol 159:655-663
199. Leader B, Baca QJ, Golan De (2008) Protein therapeutics: A summary and pharmacological classi fi cation. Nat Rev Drug Discov 7:21-39
200. Demain AL, Vaishnav P (2009) Production of recombinant proteins by microbes and higher organisms. Biotechnol Adv 27:297-306
201. Rayder RA (2008) Expression systems for process and product improvement. Bioprocess Int 6:4-9
202. Choi BK, Bobrowicz P, Davidson RC, Hamilton SR, Kung DH, Li H et al (2003) Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris . Proc Natl Acad Sci USA 100:5022-5027
203. Yuan L, Kurek I, English J, Keenan R (2005) Laboratory-directed protein evolution. Microbiol Mol Biol Rev 69:373-392
204. Terpe K (1996) Overview of bacterial expression systems for heterologous protein production: From molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 72:211-223
205. Swartz J (1996) Escherichia coli recombinant DNA technology. In: Neidhardt FC (ed) Esherichia coli and Salmonella: Cellular and molecular biology, 2nd edn. American Society of Microbiology, Washington, DC, pp 1693-1771
206. Wong MS, Wu S, Causey TB, Bennett GN, San K-Y (2008) Reduction of acetate accumulation in Escherichia coli cultures for increased recombinant protein production. Metab Eng 10:97-108
207. Morrow KJ (2009) Grappling with biologic manufacturing concerns. Genet Eng Biotechnol News 29(5):54-55
208. Choi JH, Lee SJ, Lee SJ, Lee SY (2003) Enhanced production of insulin-like growth factor I fusion protein in Escherichia coli by coexpression of the down-regulated genes identi fi ed by transcriptome profiling. Appl Environ Microbiol 69:4737-4742
209. Barnard GC, Henderson GE, Srinivasan S, Gerngross TU (2004) High level recombinant protein expression in Ralstonia eutropha using T7 RNA polymerase based amplification. Protein Expr Purif 38:264-271
210. Squires CH, Lucy P (2008) Vendor voice: A new paradigm for bacterial strain engineering. Bioprocess Int 6:22-27
211. Sreekrishana K, Nelles L, Potenz R, Cruze J, Mazzaferro P et al (1989) High level expression, purification, and characterization of recombinant human tumor necrosis factor synthesized in the methylotrophic yeast Pichia pastoris . Biochemistry 28:4117-4125
212. Werten MWT, Van Den Bosch TJ, Wind RD, Mooibroek H, De Wolf FA (1999) Highyield secretion of recombinant gelatins by Pichia pastoris . Yeast 15:1087-1096
213. Clare JJ, Rayment FB, Ballantine SP, Sreekrishna K, Romanos MA (1991) High level expression of tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integrations of the gene. Nat Biotechnol 9:455-460
214. Nevalainen KMH, Te'o VSJ, Bergquist PL (2005) Heterologous protein expression in Filamentous fungi. Trends Biotechnol 23: 468-474
215. Morrow KJ (2007) Strategic protein production. Genet Eng Biotechnol News 27:50-54
216. Gellison G, Janowicz ZA, Weydemann U, Melber K, Strasser AWM, Hollenberg CP (1992) High-level expression of foreign genes in Hansenula polymorpha . Biotechnol Adv 10:179-189
217. Meyer V (2008) Genetic engineering of Filamentous fubgi-progress, obstacles and future trends. Biotechnol Adv 26:177-185
218. Lubertozzi D, Keasling JD (2009) Developing Aspergillus as a host for heterologous expression. Biotechnol Adv 27:53-75
219. Van Hartinsveldt W, Van Zeijl CM, Harteeld GM, Gouka RJ, Suykerbuyk M, Luiten RG et al (1993) Cloning, characterization and overexpression of the phytase-encoding gene (phyA) of Aspergillus niger . Gene 127:87-94
220. Ward PP, Piddlington CS, Cunningham GA, Zhou X, Wyatt RD, Conneely OM (1995) A system for production of commercial quantities of human lactoferrin: A broad spectrum natural antibiotic. Nat Biotechnol 13:498-503
221. Christensen T, Woeldike H, Boel E, Mortensen SB, Hjortshoej K, Thim L et al (1988) High level expression of recombinant genes in Aspergillus oryzae . Nat Biotechnol 6:1419-1422
222. Headon DR, Wyatt RD (1995) Human lactoferrin from Aspergillus spp. SIM News 45:113-117
223. Verdoes JC, Punt PJ, Burlingame R, Bartels J, van Dijk R, Slump E, Meens M, Joosten R, Emalfarb M (2007) A dedicated vector for Efficient library construction and high throughput screening in the hyphal fungus Chrysosporium lucknowense . Ind Biotechnol 3:48-57
224. Andersen DC, Krummen L (2002) Recombinant protein expression for therapeutic applications. Curr Opin Biotechnol 13:117-123
225. Wrotnowski C (1998) Animal cell culture; novel systems for research and production. Genet Eng News 18(3):13-37
226. Grif fi n TJ, Seth G, Xie H, Bandhakavi S, Hu W-S (2007) Advancing mammalian cell culture engineering using genome-scale technologies. Trends Biotechnol 25:401-408
227. Decaria P, Smith A, Whitford W (2009) Many considerations in selecting bioproduction culture media. Bioprocess Int 7:44-51
228. Scott C, Montgomery SA, Rosin LJ (2007) Genetic engineering leads to microbial, animal cell, and transgenic expression systems. BIO Internat Convention, pp. 27-34
229. Morrow KJ (2007) Improving protein production processes. Genet Eng Biotechnol News 27:44-47
230. Ryll T (2008) Antibody production using mammalian cell culture-how high can we push productivity ? SIM Annual Meeting Program & Abstract, San Diego, S146, p.101
231. Meyer HP, Biass J, Jungo C, Klein J, Wenger J, Mommers R (2008) An emerging star for therapeutic and catalytic protein production. Bioprocess Int 6:10-21
232. CocoMartin JM, Harmsen MM (2008) A review of therapeutic protein expression by mammalian cells. Bioprocess Int 6:28-33
233. Jarvis LM (2008) A technology bet. DSM's pharma product unit leverages its biotech strength to survive in a tough environment. Chem Eng News 86:30-31
234. Agathos SN (1991) Production scale insect cell culture. Biotechnol Adv 9:51-68
235. Luckow VA, Summers MD (1988) Trends in the development of baculovirus expression vectors. Nat Biotechnol 6:47-55
236. Miller LK (1988) Baculoviruses as gene expression vectors. Annu Rev Microbiol 42:177-199
237. Wilkinson BE, Cox M (1998) Baculovirus expression system: The production of proteins for diagnostic, human therapeutic or vaccine use. Genet Eng News 18, 35(Nov)
238. Maiorella B, Harano D (1988) Large scale insect cell culture for recombinant protein production. Nat Biotechnol 6:1406-1409
239. Morrow KJ Jr (2007) Improving protein production processes. Genet Eng News 27(5):50-54
240. Knight P (1991) Baculovirus vectors for making proteins in insect cells. ASM News 57:567-570
241. Falch E (1991) Industrial enzymes-developments in production and application. Biotechnol Adv 9:643-658
242. Cowan D (1996) Industrial enzyme technology. Trends Biotechnol 14:177-178
243. Vohra A, Satyanarayana T (2003) Phytases: Microbial sources, production, purification, and potential biotechnological applications. Crit Rev Biotechnol 23:29-60
244. Vaishnav P, Demain AL (2009) Industrial biotechnology overview. In: Schaechter M, Lederberg J (eds) Encyclopedia of microbiology, 3rd edn. Elsevier, Oxford, p 335
245. Wackett LP (1997) Bacterial biocatalysis: Stealing a page from nature's book. Nat Biotechnol 15:415-416
246. Palva I (1982) Molecular cloning ofα-amylase gene from Bacillus amyloliquefaciens and its expression in Bacillus subtilis . Gene 19: 81-87
247. O'Neill GP, Kilburn DG, Warren RAJ, Miller RC (1986) Overproduction from a cellulase gene with a high guanosine-plus-cytosine content in Escherichia coli . Appl Environ Microbiol 52:737-743
248. Shoemaker S, Schweickart V, Ladner M, Gelfand D, Kwok S, Myambo K et al (1983) Molecular cloning of exo-cellobiohydrolase I derived from Trichoderma reesei strain L27. Nat Biotechnol 1:691-696
249. Van Brunt J (1986) Fungi: The perfect hosts? Biotechnology 4:1057-1062
250. Mondou F, Shareck F, Morosoli R, Kleupfel D (1986) Cloning of the xylanase gene of Streptomyces lividans . Gene 49:323-329
251. Van Den Burg B, Vriend G, Veltman O, Venema G, Eijsink VGH (1998) Engineering an enzyme to resist boiling. Proc Natl Acad Sci USA 95:2056-2060
252. Ness JE, Welch M, Giver L, Bueno M, Cherry JR, Borchert TV et al (1999) DNA shuf fl ing of subgenomic sequences of subtilisin. Nat Biotechnol 17:893-896
253. Jaeger KE, Reetz MT (2000) Directed evolution of enantioselective enzymes for organic chemistry. Curr Opin Chem Biol 4:68-73
254. Suenaga H, Mitsokua M, Ura Y, Watanabe T, Furukawa K (2001) Directed evolution of biphenyl dioxygenase: Emergence of enhanced degradation capacity for benzene, toluene, and alkylbenzenes. J Bacteriol 183: 5441-5444
255. Song JK, Rhee JS (2001) Enhancement of stability and activity of phospholipase A(1) in organic solvents by directed evolution. Biochim Biophys Acta 1547:370-378
256. Raillard S, Krebber A, Chen Y, Ness JE, Bermudez E, Trinidad R et al (2001) Novel enzyme activities and functional plasticity revealed by recombining highly homologous enzymes. Chem Biol 8:891-898
257. Kurtzman AL, Govindarajan S, Vahle K, Jones JT, Heinrichs V, Patten PA (2001) Advances in directed protein evolution by recursive genetic recombination: Applications to therapeutic proteins. Curr Opin Biotechnol 12:361-370
258. Marshall SH (2002) DNA shuf fl ing: Induced molecular breeding to produce new generation long-lasting vaccines. Biotechnol Adv 20:229-238
259. Locher CP, Soong NW, Whalen RG, Punnonen J (2004) Development of novel vaccines using DNA shuf fl ing and screening strategies. Curr Opin Mol Ther 6:34-39
260. Tobin MB, Gustafsson C, Huisman GW (2000) Directed evolution: The 'rational' basis for 'irrational' design. Curr Opin Struct Biol 10:421-427
261. Crameri A, Whitehorn A, Stemmer WPC (1996) Improved green fluorescent protein by molecular evolution using DNA shuf fl ing. Nat Biotechnol 14:315-319